Seoul, South Korea

Yu Heun Kim

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Cellartgen Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Heun Kim: Innovator in Organoid Technology

Introduction

Yu Heun Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of organoid technology, particularly through his innovative patent that focuses on organ extracellular matrix-derived scaffolds. His work aims to enhance the culture and transplantation of organoids, which are miniature, simplified versions of organs.

Latest Patents

Yu Heun Kim holds a patent for an "Organ extracellular matrix-derived scaffold for culture and transplantation of organoid and method of preparing the same." This patent describes a scaffold composition that includes an organ extracellular matrix, with the organ selected from the intestine, stomach, liver, and lung. The preparation of this scaffold involves decellularizing isolated organ tissue to create a decellularized organ tissue, drying it to form an organ extracellular matrix, and gelating the dried matrix. The cultured organoid is then grown within this scaffold composition, facilitating advancements in organoid research.

Career Highlights

Throughout his career, Yu Heun Kim has been associated with Cellartgen Inc., where he continues to push the boundaries of organoid technology. His innovative approach has garnered attention in the scientific community, contributing to the understanding and application of organoids in medical research and potential therapies.

Collaborations

Yu Heun Kim collaborates with talented individuals such as Jin Gu Lee and Su Kyeom Kim. Their combined expertise enhances the research and development efforts at Cellartgen Inc., fostering a collaborative environment that drives innovation.

Conclusion

In summary, Yu Heun Kim is a key figure in the advancement of organoid technology through his innovative patent and contributions at Cellartgen Inc. His work holds promise for future applications in regenerative medicine and organ transplantation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…